Anti-ABCG2 monoclonal antibody in combination with paclitaxel nanoparticles against cancer stem-like cell activity in multiple myeloma
C Yang, F Xiong, J Wang, J Dou, J Chen, D Chen… - …, 2014 - Taylor & Francis
… anti-ABCG2 monoclonal antibodies (mAbs) in combination with paclitaxel iron oxide
nanoparticles (PTX-NPs) on CD138 - CD34 - multiple myeloma (MM) cancer stem cells (CSCs) in …
nanoparticles (PTX-NPs) on CD138 - CD34 - multiple myeloma (MM) cancer stem cells (CSCs) in …
γ-Fe2O3 nanoparticles increase therapeutic efficacy of combination with paclitaxel and anti-ABCG2 monoclonal antibody on multiple myeloma cancer stem cells in …
C Yang, X He, L Song, X Zhan, Y Zhang… - … nanotechnology, 2014 - ingentaconnect.com
… Treatment with nanoparticles, paclitaxel and anti-ABCG2 antibody remarkably inhibited the
… the nanoparticle combination with paclitaxel and anti-ABCG2 monoclonal antibody offers an …
… the nanoparticle combination with paclitaxel and anti-ABCG2 monoclonal antibody offers an …
[HTML][HTML] Target therapy of multiple myeloma by PTX-NPs and ABCG2 antibody in a mouse xenograft model
C Yang, F Xiong, J Dou, J Xue, X Zhan, F Shi, M Li… - Oncotarget, 2015 - ncbi.nlm.nih.gov
… monoclonal antibody (McAb) combined with paclitaxel (PTX) … 4 nanoparticles (NPs) on MM
progressed from cancer stem … guess that anti-ABCG2 McAb may lyse MM cells by antibody-…
progressed from cancer stem … guess that anti-ABCG2 McAb may lyse MM cells by antibody-…
Induction of multiple myeloma cancer stem cell apoptosis using conjugated anti-ABCG2 antibody with epirubicin-loaded microbubbles
F Shi, M Li, J Wang, D Wu, M Pan, M Guo… - Stem Cell Research & …, 2018 - Springer
… combination of anti-ABCG2 monoclonal antibody (mAb) and paclitaxel iron oxide nanoparticles
… using EPI-loaded lipid MBs conjugated with anti-ABCG2 mAb to assess its effect on MM …
… using EPI-loaded lipid MBs conjugated with anti-ABCG2 mAb to assess its effect on MM …
Inhibitory effect of epirubicin-loaded lipid microbubbles with conjugated anti-ABCG2 antibody combined with therapeutic ultrasound on multiple myeloma cancer stem …
… with conjugated anti-ABCG2 monoclonal antibody (EPI-… combined with UTMD to investigate
the inhibitory effect on MM CSCs as marked CD138 − CD34 − phenotypes by isolated from …
the inhibitory effect on MM CSCs as marked CD138 − CD34 − phenotypes by isolated from …
Enhancing the anti-multiple myeloma efficiency in a cancer stem cell xenograft model by conjugating the ABCG2 antibody with microbubbles for a targeted delivery of …
… ) conjugated with anti-ABCG2 monoclonal antibody (mAb) … (MBs) conjugated with anti-ABCG2
mAb, in combination with … nonobese diabetic/severe combined immunodeficient (NOD/…
mAb, in combination with … nonobese diabetic/severe combined immunodeficient (NOD/…
ABC transporter-mediated multidrug-resistant cancer
… of paclitaxel iron oxide nanoparticles (PTX-NPs). When the PTX-NPs are combined with
anti-ABCG2 monoclonal antibody (… of the multiple myeloma (MM) tumor was observed, with a …
anti-ABCG2 monoclonal antibody (… of the multiple myeloma (MM) tumor was observed, with a …
ABC transporters in breast cancer: their roles in multidrug resistance and beyond
… 63], d) employing paclitaxel iron oxide nanoparticles, causing … ) or trastuzumab (HER2
monoclonal antibody) reverses the … or in combination with currently used anti-cancer agents are …
monoclonal antibody) reverses the … or in combination with currently used anti-cancer agents are …
Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters
… of drugs is one of the leading methods of cancer treatment, either by itself or in conjunction
… Some examples of anticancer drugs that stimulate ATPase activity include paclitaxel and …
… Some examples of anticancer drugs that stimulate ATPase activity include paclitaxel and …
Tamoxifen resistance induction results in the upregulation of ABCG2 expression and mitoxantrone resistance in MCF-7 breast cancer cells
… combination to treat cancers. Therefore, it is not unusual for patients affected by an advanced
malignancy to receive subsequent anti-cancer … primary monoclonal antibody Anti-ABCG2 …
malignancy to receive subsequent anti-cancer … primary monoclonal antibody Anti-ABCG2 …